Anxiety is an unpleasant complex combination of emotions often accompanied by physical sensations such as heart palpitations (irregular heart beat), nausea, angina (chest pain), shortness of breath, tension headache, and nervousness. It also distracts from concentration, memory and overall cognitive function.

Anxiety disorders affect many adults aged 18 years and older (about 18%) in a given year. However, only about one-third of those suffering from an anxiety disorder receive any treatment.

Unlike the relatively mild, brief anxiety that can be caused by a stressful event (such as testing, a job interview, the death of a loved one, or public performance/speaking), anxiety disorders last at least six months and can become worse if not treated.

Anxiety disorders can commonly occur along with other mental or physical illnesses, including alcohol or substance abuse, depression, or bipolar illness, which may mask anxiety symptoms or make them worse.

Individuals with an anxiety disorder are three to five times more likely to go to the doctor and six times more likely to be hospitalised for psychiatric disorders than non-sufferers.

Psychiatric disorders, also called psychological disorders, are illnesses of the brain that cause disruptions in a patient’s thinking, feeling, moods, and ability to relate to others. Psychiatric disorders are classified into different groups, including anxiety disorders, mood disorders, adjustment disorders, developmental disorders, somatoform disorders, dissociative disorders, personality disorders, and psychotic disorders.

Psychiatric disorders can occur in patients of all ages, genders, races, and ethnic backgrounds. The exact cause of psychiatric disorders remains unknown. Researchers believe a combination of factors, including genetics and environmental stimuli (such as traumatic events exposures and nutrient deficiencies), may lead to the development and amplification of mental illnesses.

Always seek medical advice when faced with any condition, including anxiety and depression.

Related products available at Nutri-Link:

Code Product description Type Size Supplier
72810 5-L-Hydroxytryptophan Caps 150 ARG
79014 Balancing Serotonin & Norepinephrine Levels Book 1 ARG
1282 Bio-BifidoBacT Pwdr 75g BRC
1127 Bio-Glycozyme Forte™ Caps 90 BRC
1128 Bio-Glycozyme Forte™ Caps 270 BRC
1285 BioDoph-7 Plus™ Caps 60 BRC
SP100 BodyBio Oil 4:1 Oil Liq 474ml BB
7707 Casein Concentrate (form. De-Stress™) Caps 30 BRC
1409 CLA (800mg) Caps 60 BRC
70630 L-Tyrosine, 500mg Caps 100 ARG
1724 Li-Zyme Forte™ Tabs 100 BRC
1706 Li-Zyme™ (Lithium) Tabs 100 BRC
LM403 Liquid Magnesium – No. 3 Liq 120ml BB
LM203 Liquid Magnesium – No. 3 Liq 60ml BB
3502 Meda-Stim™ Caps 100 BRC
1707 Mg-Zyme™ (Magnesium) Tabs 100 BRC
6349 Neuro-5-HTP Plus™ Caps 90 BRC
72240 Phosphatidyl Choline, 385mg Soft Gel 100 ARG
72570 PhosSerine® Complex Soft Gel 90 ARG
03090 ProEFA Xtra™ – Lemon Soft Gel 60 NN
03091 ProEFA® – 90 Soft Gels – Lemon Soft Gel 90 NN
04091 ProEFA® -180 Soft Gels – Lemon Soft Gel 180 NN
04092 ProEFA® Liquid – Lemon Liq 237ml NN
07061 ProEPA Xtra™ – 60 Soft Gels – Lemon Soft Gel 60 NN
08060 ProEPA™ – 120 Soft Gels – Lemon Soft Gel 120 NN
07060 ProEPA™ – 60 Soft Gels – Lemon Soft Gel 60 NN
13124 ProOmega-D™ – 120 Soft Gels – Lemon Soft Gel 120 NN
76020 Seratonin™ Caps 90 ARG
74060 Slumberol Tabs 100 ARG
70320 Solution of Magnesium Liq 237ml ARG
71150 Stabilium® 200 Soft Gel 30 ARG
71150(B) Stabilium® 200 x 3 Soft Gel 90 ARG
70340 Super Vitamin B Complex Caps 120 ARG
74700 Zen, 200mg of Caps 60 ARG
76650 Zen, 200mg of Caps 120 ARG

References

  1. Arranz MJ, de Leon J. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Mol Psychiatry. 2007 Jun 5; View Abstract.
  2. Fava GA, Fabbri S, Sirri L, et al. Psychological factors affecting medical condition: a new proposal for DSM-V. Psychosomatics. 2007 Mar-Apr;48(2):103-11. View PDF
  3. Hyler SE, Sussman N. Somatoform disorders: before and after DSM-III. Hosp Community Psychiatry. 1984 May;35(5):469-78.View Abstract.
  4. Modestin J, Hermann S, Endrass J. Schizoidia in schizophrenia spectrum and personality disorders: Role of dissociation. Psychiatry Res. 2007 Jun 12; View Abstract.
  5. Morgan S, Taylor E. Antipsychotic drugs in children with autism. BMJ. 2007 May 26; 334(7603):1069-70. View PDF.
ˆ Back to top
We use cookies and similar tools across our websites to improve their performance and enhance your user experience. Learn more about our Cookies Policy and click I understand, to hide this message.